Advanced BioMedical Technologies, Inc. engages in the business of designing, developing, manufacturing, and marketing biomaterial internal fixation devices. The company is headquartered in New York City, New York. The company went IPO on 2007-09-10. The Company’s primary products include Polymer Osteosynthesis Devices made of a proprietary material compositing of polyamide 6 (PA6), hydroxyapatite (HA) and poly (methyl methacrylate-co-N-vinylpyrrolidone) (P(MMA-co-NVP)). These advanced materials are used in surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, and reconstructive dental procedures. Its PA Binding Wires are under clinical trials and its PA Mini-Screws are under animal test.
Advanced Biomedical Technologies Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Advanced Biomedical Technologies Inc 주요 수익원은 Base Rent이며, 최신 수익 발표에서 수익은 72,621,000입니다. 지역별로는 United States이 Advanced Biomedical Technologies Inc의 주요 시장이며, 수익은 102,325,000입니다.
Advanced Biomedical Technologies Inc은 수익성이 있나요?
no, 최신 재무제표에 따르면 Advanced Biomedical Technologies Inc의 순손실은 $0입니다.